Showing results (1-10 of 139) with videos related to
Sort By:
Pageof 14
Medicinal Research Reviews|July 14, 2006
Plasmepsins as potential targets for new antimalarial therapyKarolina Ersmark, Bertil Samuelsson, Anders HallbergBioorganic & Medicinal Chemistry|August 7, 2003
C2-symmetric inhibitors of Plasmodium falciparum plasmepsin II: synthesis and theoretical predictionsKarolina Ersmark, Isabella Feierberg, Sinisa Bjelic, et al.Journal of Medicinal Chemistry|December 30, 2003
Potent inhibitors of the Plasmodium falciparum enzymes plasmepsin I and II devoid of cathepsin D inhibitory activityKarolina Ersmark, Isabella Feierberg, Sinisa Bjelic, et al.Journal of Medicinal Chemistry|September 16, 2005
Synthesis of malarial plasmepsin inhibitors and prediction of binding modes by molecular dynamics simulationsKarolina Ersmark, Martin Nervall, Elizabeth Hamelink, et al.Bioorganic & Medicinal Chemistry|November 26, 2005
Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IVKarolina Ersmark, Martin Nervall, Hugo Gutiérrez-de-Terán, et al.Bioorganic & Medicinal Chemistry|January 18, 2005
Cyclic sulfamide HIV-1 protease inhibitors, with sidechains spanning from P2/P2' to P1/P1'Anna Ax, Wesley Schaal, Lotta Vrang, et al.Bioorganic & Medicinal Chemistry|March 12, 2003
New potent C2-symmetric malaria plasmepsin I and II inhibitorsKarin Oscarsson, Stefan Oscarson, Lotta Vrang, et al.Bioorganic & Medicinal Chemistry|June 6, 2003
Peptide-based inhibitors of hepatitis C virus full-length NS3 (protease-helicase/NTPase): model compounds towards small molecule inhibitorsKarin Oscarsson, Anton Poliakov, Stefan Oscarson, et al.Organic & Biomolecular Chemistry|August 4, 2006
Variations of the P2 group in HIV-1 protease inhibitors containing a tertiary alcohol in the transition-state mimicking scaffoldJenny K Ekegren, Johan Gising, Hans Wallberg, et al.Journal of Medicinal Chemistry|February 21, 2003
Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytesDaniel Nöteberg, Elizabeth Hamelink, Johan Hultén, et al.Pageof 14